Variable | β | Standard Error | Chi-Square | P | HR(95% CI) |
---|---|---|---|---|---|
Age group | 0.13 | 0.30 | 0.19 | 0.6653 | 1.14(0.63 ~ 2.07) |
Menopause | 0.14 | 0.29 | 0.22 | 0.6377 | 1.15(0.65 ~ 2.03) |
Stage (early or late) | 1.03 | 0.26 | 15.78 | <.0001* | 2.79(1.68 ~ 4.64) |
Histotype | 0.26 | 0.19 | 1.87 | 0.1713 | 1.3(0.89 ~ 1.9) |
Lymph node positive | 0.22 | 0.24 | 0.84 | 0.3605 | 1.25(0.77 ~ 2.02) |
Lymphadenectomy | 0.61 | 0.23 | 6.96 | 0.0084* | 1.84(1.17 ~ 2.89) |
Residual disease | 0.48 | 0.20 | 5.75 | 0.0165* | 1.62(1.09 ~ 2.39) |
CA125 normal | 0.25 | 0.31 | 0.68 | 0.4086 | 1.29(0.71 ~ 2.36) |
Tumor side | 0.26 | 0.19 | 1.96 | 0.1619 | 1.3(0.9 ~ 1.87) |
Endometriosis | −0.66 | 0.29 | 5.15 | 0.0233* | 0.52(0.29 ~ 0.91) |
Chemotherapy group | −0.03 | 0.19 | 0.02 | 0.8773 | 0.97(0.66 ~ 1.42) |
Chemoresistance | 3.77 | 0.42 | 81.43 | <.0001* | 43.3(19.1 ~ 98.15) |